An interventional study of Quit and Screen Project training and G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training in Knowledge, Attitudes and Behavioral Intention, sponsored by University of Arkansas. Not yet recruiting at 1 site in United States. Open to participants aged 21 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by University of Arkansas · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 585 studies in Behavior with a site in United States — 87 open to participants now, 118 under way, 2 of them phase 3. Behavior · United States.
Among the 585 studies in Behavior with a site in United States, this one is the 145th largest by planned enrollment of the 495 interventional ones that give a count, is one of 3 that started in 2027, is one of 431 with no phase, reaches primary completion later than 53 of the 116 other live ones, and was the 495th registered.
1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.
Browse Behavior studies →87 of the 585 studies in Behavior with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 12–80
Healthy Tarrant County Collaboration · Sites in United States
Ages 18+
KDH Research & Communication · Sites in United States
Ages 18+ · Men only · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 18–24
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.
This study: 21 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
585 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 33 · Phase 3 14 · Phase 4 11
First in 1989; this study’s year is marked. 3 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 120 across 1,202 interventional studies indexed under Behavior.
Median enrollment 121 across the 495 interventional studies, 122 across the 89 observational. Of the 432 that completed or were terminated, 110 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 585 have an industry lead sponsor. The 10 most frequent:
University of Arkansas is the lead sponsor of 399 studies on the registry; 38 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 35 (95%) have results posted.
University of Arkansas has 4 studies filed under Behavior — fewer than ten, so there is no comparison to draw.
49 of the studies in Behavior with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07217145Phase 3University of UtahPREVENT HPV -Related Cancers Trial | 2026-11 |
| NCT06099197Indiana UniversityI-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals | 2026-11 |
| NCT04481061Children's Hospital Medical Center, CincinnatiEngaging Adolescents in Decisions About Return of Genomic Research Results | 2026-11-30 |
| NCT05677360H. Lee Moffitt Cancer Center and Research InstituteHPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) | 2026-12 |
| NCT03938610Pamela HughesDo Script Concordance Tests Correlate With Family Medicine Standardized Tests and Failing Rotation Grades? | 2026-12 |
Add all 49 to your calendar (.ics) → With an account.
Among the 585 studies in Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.
The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.
This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.
In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training .
Other: Quit and Screen Project training
In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training.
Other: Quit and Screen Project training · Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.
The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.
Familiarity with treatment guidelines for tobacco and nicotine treatment
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation
These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients
Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Provider Perceptions about patient barriers to smoking cessation
Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Behavioral intentions to screen and advise patients about smoking cessation
A set of questions based on the Theory of Planned Behavior assessed provider's intention to screen patients for tobacco use and provide them interventions and referrals for treatment.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Familiarity with lung cancer screening guidelines
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Knowledge about low dose computed tomography for lung cancer screening
Familiarity with treatment guidelines was assessed using an modified question from the questions published by Kota et al. 2022, Carter-Bawa et al. 2022, and the National Cancer Institute National Survey of Primary Care Physicians' Recommendations \& Practices for Breast, Cervical, Lung, \& Colorectal Cancer Screening.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about shared decision-making for low dose computed tomography for lung cancer screening
Questions were modified from the questions published by Forcino et al. in 2018.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening
Questions were modified from questions published by Coughlin et al. 2020.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Provider Perceptions about patient barriers to get screened for lung cancer
Perceptions about patient barriers to getting screened for lung cancer were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography
A set of questions based on the Theory of Planned Behavior assessed provider's intention to advise patients who smoke to get screened for lung cancer via low dose computed tomography.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Characteristics of enrolled healthcare providers
Study process tracking metrics will be used to assess the demographic, training, and clinical practice characteristics of providers who enroll in the training.
Time frame: This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.
Retention: Percent of providers complete the training after enrolling
Study process tracking metrics will be used to assess retention of providers who enroll in the training.
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Adherence to completing training modules: Percent of modules completed
Study process tracking metrics and training completion data will be used to assess the percent of training modules completed (i.e., the number of modules completed divided by the total available modules).
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Preferences regarding training
Questions will assess provider feedback on the online training module.
Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Satisfaction with training
Questions will assess provider satisfaction on the online training module.
Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Apr 2027, 3 months later.
Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 3 months is below that.
Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: start Sep 2026 → Jan 2027 and completion Apr 2027 → Jul 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.